ARTICLE | Clinical News
ACP-501 regulatory update
November 19, 2012 8:00 AM UTC
The European Commission granted Orphan Drug designation to AlphaCore's ACP-501 to treat familial lecithin-cholesterol acyltransferase (LCAT) deficiency, a rare, inherited disease that causes lipid ac...